Please try another search
For the fiscal year ended 31 December 2019, Cello Health PLC revenues increased 5% to £166.8M. Net income before extraordinary items decreased 34% to £4.8M. Revenues reflect Cello Health segment increase of 9% to £96.3M, Cello Signal segment increase of 1% to £70.3M, United States segment increase of 31% to £61.1M. Net income was offset by Cello Signal segment income decrease of 29% to £2.7M.
Period Ending: | Dec 31, 2019 | Jun 30, 2019 | Dec 31, 2018 | Jun 30, 2018 |
---|---|---|---|---|
Total Revenue | 166.77 | 79.52 | 158.95 | 77.19 |
Gross Profit | 107.56 | 54.46 | 100.79 | 51.01 |
Operating Income | 7.6 | 4.88 | 9.72 | 3.55 |
Net Income | -0.94 | 3.54 | 6.62 | 2.49 |
Period Ending: | Dec 31, 2019 | Jun 30, 2019 | Dec 31, 2018 | Jun 30, 2018 |
---|---|---|---|---|
Total Assets | 139.73 | 137.15 | 137.74 | 124.27 |
Total Liabilities | 57.33 | 48.55 | 50.9 | 41.13 |
Total Equity | 82.4 | 88.6 | 86.83 | 83.14 |
Period Ending: | Dec 31, 2019 | Jun 30, 2019 | Dec 31, 2018 | Jun 30, 2018 |
---|---|---|---|---|
Period Length: | 12 Months | 6 Months | 12 Months | 6 Months |
Cash From Operating Activities | 12.73 | 0.76 | 11.18 | -3.24 |
Cash From Investing Activities | -6.81 | -0.74 | -2.2 | -0.92 |
Cash From Financing Activities | -7.76 | -6.76 | -11.73 | -7.21 |
Net Change in Cash | -1.88 | -6.68 | -2.6 | -11.15 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review